whether MORE patients should get a statin for primary prevention of cardiovascular events
December 2008
You'll hear new debate about whether MORE patients should get a statin for primary prevention of cardiovascular events.
Statins have only been on the market since 1987.
They were initially approved just to lower cholesterol...without solid proof of beneficial outcomes.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: PA includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote